Phenyl Carboxamide Analogues as Spleen Tyrosine Kinase (Syk) Inhibitors

摘要

The present application claims a series of phenyl carboxamide compounds that demonstrate activity against Syk kinase protein. Such compounds could potentially be used for the treatment of conditions or disorders associated with inappropriate Syk activity such as inflammatory, allergic, and autoimmune diseases (rheumatoid arthritis, asthma, etc.).